Core Insights - The proportion of domestically registered special medical purpose formula foods has increased from 49% in 2020 to 88% by 2025 [1] - The market size for these products is projected to grow from 7 billion yuan in 2020 to 23 billion yuan by 2024, with a compound annual growth rate (CAGR) exceeding 25% [1] - The approval of special medical foods for rare diseases, such as methylmalonic acidemia, is expected to mark a breakthrough in domestic product offerings, ensuring essential nutrition for niche groups [1] - As of now, there are 293 registered special medical food products in China [1]

Core Insights - The proportion of domestically registered special medical purpose formula foods in China is expected to increase from 49% in 2020 to 88% by 2025 [1] - The market size for these products is projected to grow from 7 billion yuan in 2020 to 23 billion yuan by 2024, with a compound annual growth rate exceeding 25% [1] - The approval of special medical foods for rare diseases, such as methylmalonic acidemia, is set to break new ground in 2025, ensuring the availability of essential nutrition for niche patient groups [1] - As of now, there are 293 registered special medical food products in China [1]